FDA panel recommends first RSV vaccine from Pfizer

The Pfizer drug won narrow panel approval. That clears the way for the FDA to decide on the drug in May

Related Keywords

Hana El Sahly ,Centers For Disease ,Pfizer ,Glaxosmithkline ,Products Advisory Committee On ,Drug Administration ,Cnn ,Related Biological Products Advisory Committee ,Disease Control ,